Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 109
Selected: 0
NCT IDTitle
NCT01701063An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
NCT02249923Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
NCT02622581Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT03475628Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
NCT05486481Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
NCT02838693Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
NCT03283917Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
NCT07488156Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT02429791Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)
NCT05117931A Study of Amivantamab in People With Esophagogastric Cancer
NCT00214552Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
NCT04162366A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
NCT06396533Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
NCT03899155Pan Tumor Rollover Study
NCT04394936An Explorative Psoriasis Biomarker Study
NCT06066346A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
NCT05896748Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
NCT03939182Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
NCT04240210Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
NCT03541174A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
NCT03290950A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
NCT04268498A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
NCT03556332A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
NCT01054573VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo
NCT04407442Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
NCT03993847CLassification of Axial SpondyloarthritiS Inception Cohort
NCT02342249Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
NCT03522259Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery
NCT02172872"InDACtion" vs "3+7" Induction in AML
NCT03450057Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
NCT04116606Antidepressant Trial With P2X7 Antagonist JNJ-54175446
NCT06107738Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT02841033Daratumumab for the Treatment of Patients With AL Amyloidosis
NCT01641367A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
NCT03823924Changes in Body Composition Under Ustekinumab in PsA
NCT01717053Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
NCT05523089The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT02422797Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
NCT00001018A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
NCT00277654Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
NCT02772588AASUR in High Risk Prostate Cancer
NCT00002132Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
NCT04399551A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
NCT05285137Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects
NCT02002130The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
NCT03696160The Late Presenter Treatment Optimisation Study
NCT04371380Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants
NCT03063203Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia